您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报 (医学版) ›› 2025, Vol. 63 ›› Issue (5): 33-39.doi: 10.6040/j.issn.1671-7554.0.2024.0889

• 重点专题——动脉桥在冠脉旁路移植中的应用 • 上一篇    

糖尿病患者冠脉旁路移植手术中动脉桥的研究现状

卢圣勋,邢亚闯,罗俊辉,刘杰,何厚乐,王志强,张娜   

  1. 解放军联勤保障部队第989医院心胸外科, 河南 洛阳 471031
  • 发布日期:2025-05-07
  • 通讯作者: 罗俊辉. E-mail:ljhzzf241@163.com
  • 基金资助:
    洛阳市科技计划医疗卫生项目(1720001A-4)

Diabetic patients arterial grafts in coronary artery bypass grafting: current research status

LU Shengxun, XING Yachuang, LUO Junhui, LIU Jie, HE Houle, WANG Zhiqiang, ZHANG Na   

  1. Department of Cardiothoracic Surgery, The 989th Hospital of PLA Joint Logistic Support Force, Luoyang 471031, Henan, China
  • Published:2025-05-07

摘要: 冠状动脉旁路移植术(coronary artery bypass grafting, CABG)是治疗合并糖尿病(diabetes mellitus, DM)的严重三支冠脉病变的首选方法。动脉桥由于其远期通畅率远高于静脉桥,在CABG手术中的应用越来越多,在DM患者中的使用也日益引起关注。DM对冠脉血管的影响、对拟使用的桥动脉血管质量的影响、DM患者CABG术中多支动脉桥的应用策略和方法、不同动脉桥在DM患者中的通畅率及远期疗效等是目前研究的热点。本文就动脉桥在DM患者CABG手术中的应用及研究现状进行综述,为临床合理选择血管移植物、优化手术方案、改善DM患者CABG术后长期预后提供科学依据与参考。

关键词: 冠状动脉旁路移植术, 糖尿病, 动脉桥, 内乳动脉, 桡动脉, 远期通畅率

Abstract: Coronary artery bypass grafting(CABG)is the preferred method for severe triple-vessel coronary artery disease in patients with diabetes mellitus(DM). Due to the higher long-term patency rate compared to venous grafts, arterial grafts are increasingly used in CABG procedures, and their application in DM patients has garnered increasing attention. Current research focuses on the impact of DM on coronary vessels and the quality of potential arterial graft vessels, strategies and methods for the application of multiple arterial grafts in CABG for DM patients, and the patency rates and long-term outcomes of different arterial grafts in DM patients. This article reviews the application and current research status of arterial grafts in CABG for DM patients, aiming to provide a scientific basis and reference for the rational selection of vascular grafts in clinical practice, the optimization of surgical plans, and the improvement of the long-term prognosis of DM patients after CABG surgery.

Key words: Coronary artery bypass grafting, Diabetes mellitus, Arterial grafts, Internal mammary artery, Radial artery, Long-term patency rate

中图分类号: 

  • R587.1
[1] 国家老年医学中心, 中华医学会老年医学分会, 中国老年保健协会糖尿病专业委员会, 等. 中国老年糖尿病诊疗指南(2024版)[J]. 协和医学杂志, 2024, 15(4): 771-800. National Center of Gerontology, Chinese Society of Geriatrics, Diabetes Professional Committee of Chinese Aging Well Association, et al. Guidelines for diagnosis and treatment of senile diabetes in China(2024 edition)[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(4): 771-800.
[2] 张健, 袁戈恒. 糖尿病卒中:被忽视的大血管并发症[J]. 中华糖尿病杂志, 2020, 12(11): 864-869. ZHANG Jian, YUAN Geheng. Diabetic stroke: a neglected macrovascular complication[J]. Chinese Journal of Diabetes Mellitus, 2020, 12(11): 864-869.
[3] Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS guidelines on myocardial revascularization. the task force on myocardial revascularization of the European society of cardiology(ESC)and European association for cardio-thoracic surgery(EACTS)[J]. G Ital Cardiol(Rome), 2019, 20: 1S-61S. doi:10.1714/3203.31801
[4] Campbell PT, Newton CC, Patel AV, et al. Diabetes and cause-specific mortality in a prospective cohort of one million U.S. adults[J]. Diabetes Care, 2012, 35(9): 1835-1844.
[5] Ferrannini G, Manca ML, Magnoni M, et al. Coronary artery disease and type 2 diabetes: a proteomic study[J]. Diabetes Care, 2020, 43(4):843-851.
[6] Karagiannidis E, Moysidis DV, Papazoglou AS, et al. Prognostic significance of metabolomic biomarkers in patients with diabetes mellitus and coronary artery disease[J]. Cardiovasc Diabetol, 2022, 21(1): 70. doi:10.1186/s12933-022-01494-9
[7] Yahagi K, Kolodgie FD, Lutter C, et al. Pathology of human coronary and carotid artery atherosclerosis and vascular calcification in diabetes mellitus[J]. Arterioscler Thromb Vasc Biol, 2017, 37(2): 191-204.
[8] Carson AP, Steffes MW, Carr JJ, et al. Hemoglobin A1c and the progression of coronary artery calcification among adults without diabetes[J]. Diabetes Care, 2015, 38(1): 66-71.
[9] Zou L, Chen XJ, Chen W, et al. Comparative study on the histomorphology and molecular biology of radial artery conduits in patients with diabetes mellitus who underwent coronary bypass surgery[J]. Diab Vasc Dis Res, 2013, 10(3): 208-215.
[10] Nakajima T, Tachibana K, Takagi N, et al. Histomorphologic superiority of internal thoracic arteries over right gastroepiploic arteries for coronary bypass[J]. J Thorac Cardiovasc Surg, 2016, 151(6): 1704-1708.
[11] Lapenna D, Ciofani G, Calafiore AM, et al. Impaired glutathione-related antioxidant defenses in the arterial tissue of diabetic patients[J]. Free Radic Biol Med, 2018, 124: 525-531. doi:10.1016/j.freeradbiomed.2018.06.033
[12] Pasierski M, Staromyński J, Finke J, et al. Clinical insights to complete and incomplete surgical revascularization in atrial fibrillation and multivessel coronary disease[J]. Front Cardiovasc Med, 2022, 9: 910811. doi:10.3389/fcvm.2022.910811
[13] Misfeld M, Sandner S, Caliskan E, et al. Outcomes after surgical revascularization in diabetic patients[J]. Interdiscip Cardiovasc Thorac Surg, 2024, 38(2): ivae014. doi:10.1093/icvts/ivae014
[14] Zimarino M, Ricci F, Romanello M, et al. Complete myocardial revascularization confers a larger clinical benefit when performed with state-of-the-art techniques in high-risk patients with multivessel coronary artery disease: a meta-analysis of randomized and observational studies[J]. Catheter Cardiovasc Interv, 2016, 87(1): 3-12.
[15] Puskas JD, Sadiq A, Vassiliades TA, et al. Bilateral internal thoracic artery grafting is associated with significantly improved long-term survival, even among diabetic patients[J]. Ann Thorac Surg, 2012, 94(3): 710-715.
[16] Taggart DP, Audisio K, Gerry S, et al. Single versus multiple arterial grafting in diabetic patients at 10 years: the arterial revascularization trial[J]. Eur Heart J, 2022, 43(44): 4644-4652.
[17] Thuijs DJFM, Davierwala P, Milojevic M, et al. Long-term survival after coronary bypass surgery with multiple versus single arterial grafts[J]. Eur J Cardiothorac Surg, 2022, 61(4): 925-933.
[18] Yamaguchi A, Kimura N, Itoh S, et al. Efficacy of multiple arterial coronary bypass grafting in patients with diabetes mellitus[J]. Eur J Cardiothorac Surg, 2016, 50(3): 520-527.
[19] Schwann TA, El Hage Sleiman AKM, Yammine MB, et al. Incremental value of increasing number of arterial grafts: the effect of diabetes mellitus[J]. Ann Thorac Surg, 2018, 105(6): 1737-1744.
[20] Raza S, Blackstone EH, Houghtaling PL, et al. Influence of diabetes on long-term coronary artery bypass graft patency[J]. J Am Coll Cardiol, 2017, 70(5): 515-524.
[21] Gaudino M, Yong CM, Chadow D, et al. Coronary artery bypass surgery after transradial catheterization: implementing 2021 ACC/AHA/SCAI revascularization guidelines into clinical practice[J]. JACC Case Rep, 2022, 4(1): 27-30.
[22] Benedetto U, Gaudino M, Caputo M, et al. Right internal thoracic artery versus radial artery as the second best arterial conduit: insights from a meta-analysis of propensity-matched data on long-term survival[J]. J Thorac Cardiovasc Surg, 2016, 152(4): 1083-1091.
[23] Magouliotis DE, Fergadi MP, Zotos PA, et al. Differences in long-term survival outcomes after coronary artery bypass grafting using single vs multiple arterial grafts: a meta-analysis with reconstructed time-to-event data and subgroup analyses[J]. Gen Thorac Cardiovasc Surg, 2023, 71(2): 77-89.
[24] Navia D, Vrancic M, Piccinini F, et al. Is the second internal thoracic artery better than the radial artery in total arterial off-pump coronary artery bypass grafting? A propensity score-matched follow-up study[J]. J Thorac Cardiovasc Surg, 2014, 147(2): 632-638.
[25] Gaudino M, Lorusso R, Rahouma M, et al. Radial artery versus right internal thoracic artery versus saphenous vein as the second conduit for coronary artery bypass surgery: a network meta-analysis of clinical outcomes[J]. J Am Heart Assoc, 2019, 8(2): e010839. doi:10.1161/JAHA.118.010839
[26] Tranbaugh RF, Dimitrova KR, Lucido DJ, et al. The second best arterial graft: a propensity analysis of the radial artery versus the free right internal thoracic artery to bypass the circumflex coronary artery[J]. J Thorac Cardiovasc Surg, 2014, 147(1): 133-140.
[27] Tatoulis J. The radial artery in coronary surgery, 2018[J]. Indian J Thorac Cardiovasc Surg, 2018, 34(Suppl 3): 234-244.
[28] Cartier R, Leacche M, Couture P. Changing pattern in beating heart operations: use of skeletonized internal thoracic artery[J]. Ann Thorac Surg, 2002, 74(5): 1548-1552.
[29] Calafiore AM, Vitolla G, Iaco AL, et al. Bilateral internal mammary artery grafting: midterm results of pedicled versus skeletonized conduits[J]. Ann Thorac Surg, 1999, 67(6): 1637-1642.
[30] Galbut DL, Kurlansky PA, Traad EA, et al. Bilateral internal thoracic artery grafting improves long-term survival in patients with reduced ejection fraction: a propensity-matched study with 30-year follow-up[J]. J Thorac Cardiovasc Surg, 2012, 143(4): 844-853.
[31] Benedetto U, Altman DG, Gerry S, et al. Pedicled and skeletonized single and bilateral internal thoracic artery grafts and the incidence of sternal wound complications: insights from the Arterial Revascularization Trial[J]. J Thorac Cardiovasc Surg, 2016, 152(1): 270-276.
[32] Deja MA, Wo s S, Goba KS, et al. Intraoperative and laboratory evaluation of skeletonized versus pedicled internal thoracic artery[J]. Ann Thorac Surg, 1999, 68(6): 2164-2168.
[33] Pevni D, Mohr R, Lev-Run O, et al. Influence of bila-teral skeletonized harvesting on occurrence of deep sternal wound infection in 1, 000 consecutive patients undergoing bilateral internal thoracic artery grafting[J]. Ann Surg, 2003, 237(2): 277-280.
[34] Matsa M, Paz Y, Gurevitch J, et al. Bilateral skeleto-nized internal thoracic artery grafts in patients with diabetes mellitus[J]. J Thorac Cardiovasc Surg, 2001, 121(4): 668-674.
[35] Suma H, Tanabe H, Yamada J, et al. Midterm results for use of the skeletonized gastroepiploic artery graft in coronary artery bypass[J]. Circ J, 2007, 71(10): 1503-1505.
[36] Suzuki T, Asai T, Kinoshita T. Total arterial off-pump coronary artery bypass grafting was not associated with inferior outcomes for diabetic when compared with non-diabetic patients[J]. Interact Cardiovasc Thorac Surg, 2015, 21(6): 705-711.
[37] Shroyer ALW, Quin JA, Wagner TH, et al. Off-pump versus on-pump impact: diabetic patient 5-year coronary artery bypass clinical outcomes[J]. Ann Thorac Surg, 2019, 107(1): 92-98.
[38] Xu F, Li L, Zhou CH, et al. On-pump or off-pump impact of diabetic patient undergoing coronary artery bypass grafting 5-year clinical outcomes[J]. Rev Cardiovasc Med, 2024, 25(9): 349. doi:10.31083/j.rcm2509349
[39] Wang YS, Shi XL, Du RS, et al. Off-pump versus on-pump coronary artery bypass grafting in patients with diabetes: a meta-analysis[J]. Acta Diabetol, 2017, 54(3): 283-292.
[40] Lamy AR, Devereaux PJ, Yusuf S. Five-year outcomes after off-pump or on-pump coronary-artery bypass grafting[J]. N Engl J Med, 2017, 376(9): 894-895.
[41] Shroyer AL, Hattler B, Wagner TH, et al. Five-year outcomes after on-pump and off-pump coronary-artery bypass[J]. N Engl J Med, 2017, 377(7): 623-632.
[42] Ren QS, Li G, Chu TX, et al. Off-pump versus on-pump coronary artery bypass grafting in diabetic patients: a meta-analysis of observational studies with a propensity-score analysis[J]. Cardiovasc Drugs Ther, 2024. doi:10.1007/s10557-024-07603-y
[43] 许志锋, 凌云鹏, 崔仲奇, 等. 经左胸前外侧微创冠脉搭桥治疗冠心病多支病变[J]. 北京大学学报(医学版), 2020, 52(5): 863-869. XU Zhifeng, LING Yunpeng, CUI Zhongqi, et al. Feasibility and safety of minimally invasive cardiac coronary artery bypass grafting surgery for patients with multivessel coronary artery disease: early outcome and short-mid-term follow up results[J]. Journal of Peking University(Health Sciences), 2020, 52(5): 863-869.
[44] Zhang LF, Fu YH, Gong YC, et al. Graft patency and completeness of revascularization in minimally invasive multivessel coronary artery bypass surgery[J]. J Card Surg, 2021, 36(3): 992-997.
[45] Zhao GX, Chi LQ, Liang L, et al. The efficacy of minimally invasive coronary artery bypass grafting(mics cabg)for patients with coronary artery diseases and diabetes: a single center retrospective study[J]. J Cardiothorac Surg, 2024, 19(1): 244. doi:10.1186/s13019-024-02717-8
[46] Guo MH, Toubar O, Issa H, et al. Long-term survival, cardiovascular, and functional outcomes after minimally invasive coronary artery bypass grafting in 566 patients[J]. J Thorac Cardiovasc Surg, 2024, 168(4): 1080-1088.
[47] Nambiar P, Kumar S, Mittal CM, et al. Outcomes of bilateral internal thoracic arteries in minimally invasive coronary artery bypass grafting with analogy to the SYNTAX trial[J]. Innovations, 2019, 14(3): 227-235.
[48] Nisivaco S, Bhasin R, Kitahara H, et al. Bilateral internal thoracic artery grafting in robotic beating-heart totally endoscopic coronary artery bypass: 10-year outcomes[J]. Ann Cardiothorac Surg, 2024, 13(4): 354-363.
[49] Tiwari KK, Wadhawa V, Jawarkar M, et al. Total arterial multivessels minimal invasive direct coronary artery bypass grafting via left minithoracotomy[J]. Gen Thorac Cardiovasc Surg, 2021, 69(1): 8-13.
[50] Flather M, Dimagli A, Benedetto U, et al. Bilateral versus single internal thoracic coronary artery bypass grafting: the ART RCT[J]. Efficacy and Mechanism Evaluation, 2023. doi:10.3310/JYGF5402
[51] Farkouh ME, Domanski M, Sleeper LA, et al. Strategies for multivessel revascularization in patients with diabetes[J]. N Engl J Med, 2012, 367(25): 2375-2384.
[52] Tranbaugh RF, Dimitrova KR, Friedmann P, et al. Coronary artery bypass grafting using the radial artery: clinical outcomes, patency, and need for reintervention[J]. Circulation, 2012, 126(Suppl 1): 170-175.
[53] di Bacco L, Repossini A, Muneretto C, et al. Long-term outcome of total arterial myocardial revascularization versus conventional coronary artery bypass in diabetic and non-diabetic patients: a propensity-match analysis[J]. Cardiovasc Revasc Med, 2020, 21(5): 580-587.
[54] Gharibeh L, Ferrari G, Ouimet M, et al. Conduits biology regulates the outcomes of coronary artery bypass grafting[J]. JACC Basic Transl Sci, 2021, 6(4): 388-396.
[55] Hamilton GW, Theuerle J, Chye D, et al. Graft patency and clinical outcomes in patients with radial artery grafts previously instrumented for cardiac catheterization[J]. Circ Cardiovasc Interv, 2024, 17(7): e013739. doi:10.1161/CIRCINTERVENTIONS.123.013739
[56] Buxton BF, Shi WY, Tatoulis J, et al. Total arterial revascularization with internal thoracic and radial artery grafts in triple-vessel coronary artery disease is associated with improved survival[J]. J Thorac Cardiovasc Surg, 2014, 148(4): 1238-1243.
[57] Ruttmann E, Fischler N, Sakic A, et al. Second internal thoracic artery versus radial artery in coronary artery bypass grafting: a long-term, propensity score-matched follow-up study[J]. Circulation, 2011, 124(12): 1321-1329.
[58] Tsuneyoshi H, Komiya T, Shimamoto T, et al. The second best arterial graft to the left coronary system in off-pump bypass surgery: a propensity analysis of the radial artery with a proximal anastomosis to the ascending aorta versus the right internal thoracic artery[J]. Gen Thorac Cardiovasc Surg, 2015, 63(6): 335-342.
[59] Qureshi SH, Boulemden A, Darwin O, et al. Multiarterial coronary grafting using the radial artery as a second arterial graft: how far does the survival benefit extend?[J]. Eur J Cardiothorac Surg, 2021, 61(1): 216-224.
[60] Gaudino M, Alexander JH, Bakaeen FG, et al. Randomized comparison of the clinical outcome of single versus multiple arterial grafts: the ROMA trial-rationale and study protocol[J]. Eur J Cardiothorac Surg, 2017, 52(6): 1031-1040.
[1] 陈绪军,何国伟. 着力进一步推进动脉桥在我国冠心病冠脉旁路移植术中的应用[J]. 山东大学学报 (医学版), 2025, 63(5): 1-5.
[2] 肖飞,王联群,季强. STS多支动脉冠脉旁路移植应用解读[J]. 山东大学学报 (医学版), 2025, 63(5): 6-11.
[3] 陈绪军,申林,陈军,于涛,曹广庆,肖飞. 解剖完全再血管化是冠心病外科治疗的新策略[J]. 山东大学学报 (医学版), 2025, 63(5): 12-17.
[4] 国科,陈绪军,郑宝石,黄克力,王晓武,陈景伟,林宇,罗俊辉,王海晨,王振东,廖成全,李有金,陈文生. 解剖完全再血管化全动脉冠脉旁路移植术多中心应用中期结果[J]. 山东大学学报 (医学版), 2025, 63(5): 18-25.
[5] 国科,陈绪军,郑宝石,施超,黄克力,曹勇,陈军,吴东凯,张晓慎,罗俊辉,申林,莫绪明,杨岷,王晓武,雷印胜,田茂州,王振东,孟自力,孙忠东,李有金,陆辉辉,孟春营,高峰,陈黔苏,郭能瑞,柳德斌,张楠,林宇,陈文生,宋保国,方智,王海晨,廖晓波,徐朝军. 快通道拔管在全动脉冠脉旁路移植术的多中心临床效果[J]. 山东大学学报 (医学版), 2025, 63(5): 26-32.
[6] 杜学识,倪向敏,梁馨予,白倩,朱文艺,王建. 雌马酚对DN的保护作用及潜在靶点[J]. 山东大学学报 (医学版), 2024, 62(8): 49-58.
[7] 许沛晨,李晓博,庄向华,娄能俊,吕丽,周玲雁,牟亚朋,宋玉文,陈诗鸿. 儿童Alstrom综合征2例并文献复习[J]. 山东大学学报 (医学版), 2024, 62(3): 107-111.
[8] 张熙伟,任琳玮,张辉,张歆杰,刘伟国,王东. 左胸廓内动脉联合桡动脉行冠状动脉旁路移植术早期临床疗效[J]. 山东大学学报 (医学版), 2024, 62(3): 39-46.
[9] 林晓倩,封茂燕,牟正. 二肽基肽酶-4抑制剂的药学特点及临床应用[J]. 山东大学学报 (医学版), 2024, 62(12): 43-48.
[10] 于丹凤,曹娟,于世佳,杜鲁涛,侯新国. 电化学发光法与液相色谱-串联质谱法评估糖尿病患者维生素D缺乏程度的效能比较与界值确定[J]. 山东大学学报 (医学版), 2023, 61(7): 90-95.
[11] 李金泉,高美芳,闫飞,董明. 136例2型糖尿病患者肌肉痉挛的发生频率及危险因素[J]. 山东大学学报 (医学版), 2023, 61(5): 20-24.
[12] 张天鑫,张婷,黄鑫,韩佳沂,王淑康. 氨基酸与2型糖尿病因果关系的孟德尔随机化分析[J]. 山东大学学报 (医学版), 2023, 61(5): 102-107.
[13] 黄珊,娄能俊,韩晓琳,梁中昊,华梦羽,庄向华,陈诗鸿. 高糖环境下Lipin1对神经元代谢组学的影响[J]. 山东大学学报 (医学版), 2023, 61(2): 1-8.
[14] 包瑾瑾,刘庆燕,孙甜甜,陈青,刘佳. 糖尿病相关抗体阳性合并MODY14相关APPL1基因突变1例[J]. 山东大学学报 (医学版), 2023, 61(12): 113-118.
[15] 韩梅,孟维静,陶子琨,杨希,徐雅琪,穆华夏,卜伟晓,王素珍,石福艳. 基于G-计算的高血压、抑郁在2型糖尿病与认知功能之间的因果多中介分析[J]. 山东大学学报 (医学版), 2023, 61(10): 101-108.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!